1,2-bis(3,5-dioxopiperazin-1-yl)ethane has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldman, HD; Lee, HJ; Witiak, DT; Zwilling, BS | 1 |
| De-Oliveira, MM; Giannotti Filho, O; Joussef, AC; Nakamura, IT | 1 |
2 other study(ies) available for 1,2-bis(3,5-dioxopiperazin-1-yl)ethane and Cancer of Lung
| Article | Year |
|---|---|
Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cricetinae; Lung Neoplasms; Male; Mesocricetus; Molecular Conformation; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Structure-Activity Relationship | 1978 |
Intratumor chemotherapy in combination with a systemic antimetastatic drug in the treatment of Lewis-lung carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromans; Injections; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Polymers; Razoxane | 1985 |